Matthew Ferguson Aziyo Biologics, Inc. (AZYO) insider trading activity

Matthew Ferguson is CHIEF FINANCIAL OFFICER of AZIYO BIOLOGICS, INC.. Currently has a direct ownership of 318,744 shares of AZYO, which is worth approximately $462,178. The most recent transaction as insider was on Dec 10, 2024, when has been sold 4,461 shares (Class A Common Stock) at a price of $4.29 per share, resulting in proceeds of $19,137. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 319K

2.59% 3M change

164.48% 12M change

Total Value Held $462,178

Matthew Ferguson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 10 2024	SELL Payment of exercise price or tax liability	$19,137 $4.29 p/Share	4,461 Reduced 1.38%	318,744 Class A Common Stock
Dec 10 2024	BUY Exercise of conversion of derivative security	-	12,500 Added 3.72%	323,205 Class A Common Stock
Sep 10 2024	SELL Payment of exercise price or tax liability	$43,581 $4.14 p/Share	10,527 Reduced 3.28%	310,705 Class A Common Stock
Sep 10 2024	BUY Exercise of conversion of derivative security	-	29,500 Added 8.41%	321,232 Class A Common Stock
Aug 12 2024	SELL Payment of exercise price or tax liability	$50,665 $2.84 p/Share	17,840 Reduced 5.8%	289,983 Class A Common Stock
Aug 12 2024	BUY Exercise of conversion of derivative security	-	50,000 Added 13.97%	307,823 Class A Common Stock
Jul 31 2024	BUY Exercise of conversion of derivative security	$150,264 $1.43 p/Share	105,080 Added 28.96%	257,823 Class A Common Stock
Jun 10 2024	SELL Payment of exercise price or tax liability	$30,952 $3.47 p/Share	8,920 Reduced 5.52%	152,743 Class A Common Stock
Jun 10 2024	BUY Exercise of conversion of derivative security	-	25,000 Added 13.39%	161,663 Class A Common Stock
Mar 08 2024	SELL Payment of exercise price or tax liability	$1,710 $3.24 p/Share	528 Reduced 0.43%	121,279 Class A Common Stock
Mar 08 2024	BUY Exercise of conversion of derivative security	-	1,288 Added 1.05%	121,807 Class A Common Stock
Sep 21 2023	BUY Grant, award, or other acquisition	-	70,053 Added 36.76%	120,519 Class A Common Stock
Mar 08 2023	BUY Exercise of conversion of derivative security	-	1,287 Added 2.69%	46,504 Class A Common Stock
Dec 05 2022	BUY Open market or private purchase	$91,960 $4.18 p/Share	22,000 Added 32.73%	45,217 Class A Common Stock
Dec 02 2022	BUY Open market or private purchase	$24,180 $4.03 p/Share	6,000 Added 20.54%	23,217 Class A Common Stock
Sep 08 2022	SELL Payment of exercise price or tax liability	$35,025 $7.3 p/Share	4,798 Reduced 21.79%	17,217 Class A Common Stock
Sep 08 2022	BUY Exercise of conversion of derivative security	-	13,874 Added 38.66%	22,015 Class A Common Stock
Mar 08 2022	BUY Exercise of conversion of derivative security	-	1,288 Added 13.66%	8,140 Class A Common Stock
May 11 2021	BUY Open market or private purchase	$11,000 $11.0 p/Share	1,000 Added 30.3%	2,300 Class A Common Stock
May 10 2021	BUY Open market or private purchase	$14,482 $11.14 p/Share	1,300 Added 50.0%	1,300 Class A Common Stock

Matthew Ferguson

CHIEF FINANCIAL OFFICER

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AZYO shares.

Notify only if

Value

Insider Trading

Get notified when an Aziyo Biologics, Inc. insider buys or sells AZYO shares.

Notify only if

Operation

Value

Type

News

Receive news related to AZIYO BIOLOGICS, INC.

Track Activities on AZYO

Account